@joshuapalmermd is holding court giving a great talk showing the benefit of alpha particle therapy for patients with brain tumors at SNO 2026 in Philly
Latest posts 5
We are now enrolling patients in the Athena 2 trial comparing HA-WBRT to MA-WBRT! Open at @RadOncUH in Cleveland, opening soon at Ohio State.
Check out our phase 2 trial using Memory avoidant (MA)WBRT, improved cognitive preservation compare to historical HA-WBRT. Out now in Neuro Onc advancesView quoted post on X
academic.oup.com/noa/advance-ar…
Congratulations to @QingLi_MDPhD presenting on radiation enhancing the efficacy of HER2 ADCs as an oral presentation at the ASCO/SNO CNS Metastasis 2026 Conference. @TyMillerLab @DrSpratticus @KashaniRojano @lauren_henke @angela_jia.
This is an exciting trial that shows the importance of neuropsychologist integration into a brain tumor program. There are many more pending publications from these data examining MA-WBRT, predictors of neurocognitive decline, and predictors of changes in PROs, stay tuned.
@HaleyPerlow @OSUCCC_James @OhioStateRadOnc @ASTRO_org @NeuroOnc, big effort coordinating a trial across our neuropsych team and Dr. Dawson, accruing the phase 2, 100 patient all in one year with detailed cognitive assessments, huge effort form all the teamsView quoted post on X
These presentations will show the significant impacts of neuropsychiatric intervention, and also previously unexamined predictors of cognitive decline which will drive better selection for cognitive interventions. See everyone there!
In preparation for ASTRO, please check out these practice changing abstracts showing the benefits of adding early neuropsychiatric care for patients with brain mets. @HaleyPerlow @OhioStateRadOnc @ASTRO_org @NeuroOncView quoted post on X